My CPNP

My CPNP provides quick access to the most important features on cpnp.org.

You will see your important notices, and you will have direct access to your exams and other action items.

Log in now to see your personalized page.

User login

Industry News

Newcorn JH, Kratochvil CJ, Allen AJ, et al. Atomoxetine and osmotically released methylphenidate for the treatment of attention deficit hyperactivity disorder: acute comparison and differential response. am J Psychiatry 2008;165(6):721-30. doi:10.1176/appi.ajp.2007.05091676.
OBJECTIVE: Response to atomoxetine, a nonstimulant norepinephrine-specific reuptake inhibitor, was compared with the effect of osmotic-release oral methylphenidate, a long-acting methylphenidate preparation, in patients with attention deficit hyperactivity disorder (ADHD). METHOD: In a large placebo-controlled, double-blind study, patients ages 6-16 with ADHD, any subtype, were randomly assigned to receive 0.8-1.8 mg/kg per day of atomoxetine (N=222), 18-54 mg/day of osmotically released methylphenidate (...
Murray DW, Arnold LE, Swanson J, et al. A clinical review of outcomes of the multimodal treatment study of children with attention-deficit/hyperactivity disorder (MTA). curr Psychiatry Rep 2008;10(5):424-31.
Over the past decade, the Multimodal Treatment Study of Children with Attention-Deficit/Hyperactivity Disorder has provided a bewildering wealth of data (more than 70 peer-reviewed articles) addressing treatment-related questions for children with attention-deficit/hyperactivity disorder. However, the take-home messages for clinicians may not always be clear. Therefore, this article reviews key findings, including relative benefits of medication and behavioral treatments, long-term effects at 2 and 3 years...

CPNP News

College of Psychiatric and Neurologic Pharmacists Announces Election of 2015-2017 Officers

The College of Psychiatric and Neurologic Pharmacists (CPNP) membership has elected three officers to serve on the 2015-2017 Board of Directors. Assuming their offices effective July 1, 2015, will be Drs. Sara Dugan, Robert Haight, and Christopher Thomas.

Newly elected Board members will fill the following roles on the Board:

College of Psychiatric and Neurologic Pharmacists Announces Slate for 2015-2017 Board Officer Election

The College of Psychiatric and Neurologic Pharmacists (CPNP) Nominations Committee is pleased to announce the consideration of over 25 individuals for 3 positions on the 2015-2017 CPNP Board of Directors. Now narrowed to a slate of 6 candidates, CPNP active members will have the opportunity to select 1 individual to serve in each position. Elections will take place online at cpnp.org from November 3-21, 2014. A link to the voting center will be sent via email to all active members on November 3.

Candidates Include:

President-Elect Candidates:

The College of Psychiatric and Neurologic Pharmacists (CPNP) Announces the Recipient of the 2015 Judith J. Saklad Memorial Award

The College of Psychiatric and Neurologic Pharmacists (CPNP) is pleased to announce the recipient of the 2015 Judith J. Saklad Memorial Award, Carla Cobb, PharmD, BCPP. Dr. Cobb is a Psychiatric Pharmacist at RiverStone Health Clinic in Billings, Montana.

CPNP Generates Buzz at the NAMI Annual Meeting

The National Alliance on Mental Illness (NAMI) held their national convention in Washington, D.C., September 3-6. The popular CPNP “Ask the Psychiatric Pharmacist” booth received special mention in NAMI’s post-convention video update from Mary Giliberti, NAMI Executive Director.

In the recorded interview (timestamp 2:25-3:25), CPNP member Judy Curtis explains who CPNP is and what neuropsychiatric pharmacists contribute to patient care. CPNP student members Kayla Tegeler and Marcus Ellis, with assistance from Heidi Wehring, PharmD, BCPP, staffed the “Ask the Psychiatric Pharmacist” booth and shared the type of questions they answered at the very popular booth.

CPNP has had a long-lasting relationship with NAMI staffing the Ask the Psycyhiatric Pharmacist booth and providing 2 educational sessions (Medication and Treatment Challenges for the Young Adults and New Psychiatric Medications: Knowledge is Power) as a way to reinforce the important role psychiatric pharmacists can bring to the treatment team. A special thanks to all of the volunteers who represented CPNP and provided valuable services at NAMI 2014: Shelly Spollen, Karen Moeller, Judy Curtis, LaGenia Bailey, Alice Mascialino, Heidi Wehring, Kayla Tegeler, Marcus Ellis, Jerry Overman, and Cassidy Zammit.

Get to Know your Board of Directors for 2014-2015

July 1 is the start of CPNP’s fiscal year and the transition of officers on the Board of Directors. We express a wealth of thanks and gratitude to board members who concluded their board term as of June 30, 2014.

College of Psychiatric and Neurologic Pharmacists (CPNP) 2014 Annual Meeting

Phoenix, Arizona served as host city for the College of Psychiatric and Neurologic Pharmacist’s 17th Annual Meeting held April 27-30. This four-day conference hosted 625 attendees and featured nearly 30 hours of cutting-edge scientific presentations, three industry supported symposium, two product theaters and a display of 169 scientific posters. Deanna Kelly, PharmD, BCPP, Professor, University of Maryland, Baltimore, MD, served as Program Chair of the CPNP Annual Meeting.

The College of Psychiatric and Neurologic Pharmacists (CPNP) Announces Saklad Memorial Award and Research Award Recipients Presented at the 2014 CPNP Annual Meeting

Saklad Memorial Award

CPNP was honored to present the Saklad Memorial Award at the 2014 CPNP Annual Meeting for the seventeenth time. This award celebrates the life and work of the late Judith J. Saklad. Dr. Saklad was a founding member of CPNP and nationally recognized as an innovator of pharmaceutical care to children and adults with serious mental disorders, developmental disabilities and mental retardation. The 2014 recipient is Dr. Cynthia Kirkwood.

If you have any questions, please contact us.